Suture Anchor Devices Market

By Product;

Absorbable and Non-Absorbable

By Tying Type;

Knotted Suture Anchors and Knotless

By Material;

Metallic Suture Anchor, Bio-Absorbable Suture Anchor and Others

By End Use;

Hospitals, Ambulatory Surgical Centres and Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn826112464 Published Date: November, 2025 Updated Date: December, 2025

Suture Anchor Devices Market Overview

Suture Anchor Devices Market (USD Million)

Suture Anchor Devices Market was valued at USD 666.31 million in the year 2024. The size of this market is expected to increase to USD 918.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.


Suture Anchor Devices Market

*Market size in USD million

CAGR 4.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.7 %
Market Size (2024)USD 666.31 Million
Market Size (2031)USD 918.97 Million
Market ConcentrationHigh
Report Pages326
666.31
2024
918.97
2031

Major Players

  • Smith & Nephew plc
  • Zimmer Biomet Holdings Inc
  • ConMed Corporation
  • Arthrex Inc
  • Johnson and Johnson (DePuy Synthes, Inc.)
  • Medtronic plc
  • Stryker Corporation
  • Parcus Medical LLC
  • Anika Therapeutics
  • Stryker
  • OSSIO

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Suture Anchor Devices Market

Fragmented - Highly competitive market without dominant players


Suture Anchor Devices Market is experiencing robust growth as orthopedic surgeons and sports medicine specialists increasingly adopt high-strength implant anchors for tendon and ligament repair. Nearly 65% of repair procedures now use bioabsorbable or all‑suture anchors to ensure secure fixation. This uptick is driving innovation and market expansion, supported by collaboration between clinical experts and medical device engineers.

Anchor Design Enhancing Surgical Precision
Around 62% of manufacturers are rolling out anchors with advancements such as dual‑load suturing capability, polymer–metal hybrid structures, biodegradable materials, and color‑coded sizing. These technological advancements enhance fixation strength and surgical efficiency. Joint efforts between surgeons and R&D teams are accelerating improved anchor design.

Clinical Programs Boosting Adoption Rates
Collaborative clinical studies and adoption programs involving orthopedic hospitals, device innovators, and surgical training centers have resulted in a 59% increase in utilization of advanced anchor systems. These cross-functional collaborations ensure anatomically precise placement techniques, surgeon certification, and outcome monitoring—driving growth through procedural excellence.

Next‑Gen Anchor Technology Leading Surgical Evolution
Looking forward, over 70% of next-generation anchor devices are expected to incorporate smart suture tracking, integrated tension sensors, and bioactive surface coatings promoting tissue integration. These innovations mark a shift toward adaptive surgical fixation solutions, enabling real‑time feedback, enhanced healing, and reduced revision rates.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Tying Type
    3. Market Snapshot, By Material
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Suture Anchor Devices Market Forces
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Ligament reconstruction

        2. Biomechanical properties

        3. Healthcare infrastructure

        4. Healthcare expenditure

      2. Restraints
        1. Product recalls or quality issues

        2. Healthcare budget constraints

        3. Reimbursement issues

        4. Supply chain disruptions

      3. Opportunities
        1. Aging Population

        2. Next-Generation Designs

        3. Biomechanical Improvements

        4. Enhanced Surgical Outcomes

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Suture Anchor Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Absorbable
      2. Non-Absorbable
    2. Suture Anchor Devices Market, By Tying Type, 2021 - 2031 (USD Million)
      1. Knotted Suture Anchors
      2. Knotless
    3. Suture Anchor Devices Market, By Material, 2021 - 2031 (USD Million)
      1. Metallic Suture Anchor
      2. Bio-Absorbable Suture Anchor
      3. Others
    4. Suture Anchor Devices Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centres
      3. Clinics
    5. Suture Anchor Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Smith & Nephew plc
      2. Zimmer Biomet Holdings, Inc.
      3. CONMED Corporation
      4. Arthrex, Inc.
      5. Johnson & Johnson
      6. Stryker Corporation
      7. Medtronic plc
      8. Wright Medical
      9. Parcus Medical LLC
      10. Enovis Corporation
      11. Integra LifeSciences Corporation
      12. Teknimed
      13. Anika Therapeutics, Inc.
      14. Orthomed, Inc.
      15. B. Braun
  7. Analyst Views
  8. Future Outlook of the Market